Duration and clinical outcomes of dual antiplatelet therapy following percutaneous coronary intervention for acute coronary syndrome: A multicentre “real-world practice” registry-based study

BACKGROUND: The optimal duration of dual antiplatelet therapy (DAPT) ought to be determined taking into account individual ischaemic or bleeding events risks. To date, studies have provided inconclusive evidence on the effects of prolonged DAPT. We sought to evaluate the long-term outcomes of this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Vergara-Uzcategui, Carlos E., Moreno, Víctor H., Hennessey, Breda, Sánchez-del-Hoyo, Rafael, Donis, José H., Gonzalez-Rojas, Jorgelys, Salinas, Pablo, Nombela-Franco, Luis, Gonzalo, Nieves, Jimenez-Quevedo, Pilar, Mejia-Renteria, Hernán, Escaned, Javier, Fernández Ortiz, Antonio, Macaya Miguel, Carlos, Núñez-Gil, Iván J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117825/
https://www.ncbi.nlm.nih.gov/pubmed/37089881
http://dx.doi.org/10.3389/fcvm.2023.1158466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117825/
https://www.ncbi.nlm.nih.gov/pubmed/37089881
http://dx.doi.org/10.3389/fcvm.2023.1158466

Ejemplares similares